Effect of Tanreqing Injection in various formula compatibilities on pharmacokinetics of main components
10.7501/j.issn.0253-2670.2013.21.016
- Author:
Shao-Yong LIU
1
Author Information
1. Shanghai Kaibao Pharmaceutical Co. Ltd.
- Publication Type:Journal Article
- Keywords:
Baicalin;
Chenodeoxycholic acid;
Compatibility;
Tanreqing Injection;
Ursodeoxycholic acid
- From:
Chinese Traditional and Herbal Drugs
2013;44(21):3030-3034
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To study the pharmacokinetic effect of three active markers, baicalin (BC), ursodeoxycholic acid (UDCA), and chenodeoxycholic acid (CDCA) in plasma of rats after iv administration of Tanreqing Injection (TI) in various compatibilities, which contained scutellaria extraction (SE), bear gall powder extraction (BE), Cornu caprae hircus extraction (CE) and Lonicerae Flos extraction (FE), including SE, BE, SE-BE (SE and BE), SE-CE (SE and CE), SE-BE-CE (SE, BE and CE), and SE-BE-CE-FE (SE, BE, CE, and FE):. To discuss the rationality of TI compatibility, the effects of TI in various compatibilities on the pharmacokinetics of BC, UDCA, and CDCA in plasma of rats were investigated. Methods: Thirty-six experimental rats were randomly divided into six groups, and treated with SE, BE, SE-BE, SE-CE, SE-BE-CE, and SE-BE-CE-FE. After the simultaneous extraction of the three major bioactive components in plasma of rats, the concentration of BC was determined using LC-UV method, and UDCA as well as CDCA was determined using LC-MS method. The experimental data were analyzed by WinNonlin 6.3 software and the pharmacokinetic parameters of BC, UDCA, and CDCA in these recipes were evaluated. Results: The pharmacokinetic parameters of UDCA and CDCA did not change after iv administration of TI in various compatibilities. However, the TI in various compatibilities increased the AUC of BC after iv administration. The change degrees were SE < SE-CE < SE-BE-CE < SE-BE-CE-FE but with no statistical significance. The pharmacokinetic parameters of UDCA and CDCA did not obviously change, which indicated that the different compatibilities did not change the pharmacokinetic behavior of UDCA and CDCA. Conclusion: TI in various compatibelities could increase the exposure of BC following the iv administration, but could not affect the pharmacokinetic behaviors of UDCA and CDCA.
